Nang Kuang Pharmaceutical Co., Ltd. (1752) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nang Kuang Pharmaceutical Co., Ltd. (1752:TWSE), powered by AI.

Current Price
$35.55
P/E Ratio
14.7
Market Cap
3.6B
Sector
Healthcare
What is the Nang Kuang Pharmaceutical Co., Ltd. stock price forecast?

Nang Kuang Pharmaceutical Co., Ltd. is currently trading at $35.55. View real-time AI analysis on Alpha Lenz.

What is Nang Kuang Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Nang Kuang Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Nang Kuang Pharmaceutical Co., Ltd.'s P/E ratio?

Nang Kuang Pharmaceutical Co., Ltd.'s P/E ratio is 14.7.

Nang Kuang Pharmaceutical Co., Ltd.

TWSE · 1752
NT$35.55
Ask about Nang Kuang Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Nang Kuang Pharmaceutical Co., Ltd. trades at a P/E of 14.7 (undervalued) with solid ROE of 10.1%.

Ask for details

Company Overview

Nang Kuang Pharmaceutical Co., Ltd. operates as a prominent entity within the pharmaceutical industry, specializing in the development, manufacturing, and sale of health-focused products. The company plays a vital role in the healthcare sector by producing a wide range of pharmaceuticals, including prescription drugs, over-the-counter medications, and biopharmaceuticals. It is known for its commitment to research and development, consistently striving to enhance its product offerings and address various therapeutic needs. Nang Kuang Pharmaceutical significantly impacts both domestic and international markets by exporting its high-quality products across the globe. Its operations support critical health infrastructures and contribute to the availability of essential medicine in various regions, reinforcing its importance in the global pharmaceutical supply chain. With a focus on innovation and quality, Nang Kuang Pharmaceutical Co., Ltd. remains a key player in addressing evolving healthcare challenges and requirements.

SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2024

Profile

NT$3.59BMarket Cap
NT$2.20BRevenue
0.00Shares Out
0Employees

Margins

33.99%Gross
22.23%EBITDA
13.98%Operating
13.78%Pre-Tax
11.06%Net

Valuation

14.75P/E
1.48P/B
1.63EV/Sales
8.03EV/EBITDA
-60.35P/FCF

Growth (CAGR)

7.31%Rev 3Yr
4.54%Rev 5Yr
6.24%Op Inc 3Yr
4.40%Op Inc 5Yr
7.47%Net Inc 3Yr
2.28%Net Inc 5Yr

Returns

6.35%ROA
10.14%ROE
8.05%ROIC

Financial Health

NT$301.54MCash & Cash Equivalents
NT$1.09BNet Debt
57.43%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Nang Kuang Pharmaceutical Co., Ltd. (ticker: 1752) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies). Market cap is $3.6B.

The current price is 35.55 with a P/E ratio of 14.75x and P/B of 1.48x.

ROE is 10.14% and operating margin is 13.98%. Annual revenue is $2.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Nang Kuang Pharmaceutical Co., Ltd. (Healthcare) Stock Forecast & Analysis $35.55 | Alpha Lenz